KEAP1 and neoplasm: Two lung adenocarcinoma patients with KEAP1 received standard therapy of albumin paclitaxel + carboplatin + Coreda for 3 months after tumour proportion score (TPS) of PD-L1 Immunohistochemical test showed 95% and 90% respectively (Figure 7A1,A2).